Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 42

1.

Mechanism for fetal hemoglobin induction by histone deacetylase inhibitors involves gamma-globin activation by CREB1 and ATF-2.

Sangerman J, Lee MS, Yao X, Oteng E, Hsiao CH, Li W, Zein S, Ofori-Acquah SF, Pace BS.

Blood. 2006 Nov 15;108(10):3590-9.

2.

Short-chain fatty acids induce gamma-globin gene expression by displacement of a HDAC3-NCoR repressor complex.

Mankidy R, Faller DV, Mabaera R, Lowrey CH, Boosalis MS, White GL, Castaneda SA, Perrine SP.

Blood. 2006 Nov 1;108(9):3179-86.

3.

Fetal hemoglobin induction by histone deacetylase inhibitors involves generation of reactive oxygen species.

Hsiao CH, Li W, Lou TF, Baliga BS, Pace BS.

Exp Hematol. 2006 Mar;34(3):264-73.

PMID:
16543060
4.
5.

Thalidomide derivative CC-4047 inhibits osteoclast formation by down-regulation of PU.1.

Anderson G, Gries M, Kurihara N, Honjo T, Anderson J, Donnenberg V, Donnenberg A, Ghobrial I, Mapara MY, Stirling D, Roodman D, Lentzsch S.

Blood. 2006 Apr 15;107(8):3098-105.

6.

Fetal hemoglobin induction by the histone deacetylase inhibitor, scriptaid.

Johnson J, Hunter R, McElveen R, Qian XH, Baliga BS, Pace BS.

Cell Mol Biol (Noisy-le-grand). 2005 Sep 5;51(2):229-38.

PMID:
16171558
7.
8.

Immunomodulatory derivative of thalidomide (IMiD CC-4047) induces a shift in lineage commitment by suppressing erythropoiesis and promoting myelopoiesis.

Koh KR, Janz M, Mapara MY, Lemke B, Stirling D, Dörken B, Zenke M, Lentzsch S.

Blood. 2005 May 15;105(10):3833-40.

9.
10.

p38 MAP kinase activation mediates gamma-globin gene induction in erythroid progenitors.

Pace BS, Qian XH, Sangerman J, Ofori-Acquah SF, Baliga BS, Han J, Critz SD.

Exp Hematol. 2003 Nov;31(11):1089-96.

PMID:
14585374
11.

Thalidomide embryopathy.

LENZ W, KNAPP K.

Arch Environ Health. 1962 Aug;5:100-5. No abstract available.

PMID:
14464040
12.

Induction of human gamma globin gene expression by histone deacetylase inhibitors.

Cao H, Stamatoyannopoulos G, Jung M.

Blood. 2004 Jan 15;103(2):701-9.

13.

Thalidomide down-regulates the expression of VEGF and bFGF in cisplatin-resistant human lung carcinoma cells.

Li X, Liu X, Wang J, Wang Z, Jiang W, Reed E, Zhang Y, Liu Y, Li QQ.

Anticancer Res. 2003 May-Jun;23(3B):2481-7.

PMID:
12894531
14.

Effects of oxidative stress on human erythroid colony formation: Modulation by gamma-interferon.

Dallalio G, Means RT Jr.

J Lab Clin Med. 2003 Jun;141(6):395-400.

PMID:
12819637
15.

The effect of oxidative stress on histone acetylation and IL-8 release.

Tomita K, Barnes PJ, Adcock IM.

Biochem Biophys Res Commun. 2003 Feb 7;301(2):572-7.

PMID:
12565901
16.

Fetal hemoglobin modulation during human erythropoiesis: stem cell factor has "late" effects related to the expression pattern of CD117.

Wojda U, Leigh KR, Njoroge JM, Jackson KA, Natarajan B, Stitely M, Miller JL.

Blood. 2003 Jan 15;101(2):492-7.

17.

Induction of fetal hemoglobin expression by the histone deacetylase inhibitor apicidin.

Witt O, Monkemeyer S, Rönndahl G, Erdlenbruch B, Reinhardt D, Kanbach K, Pekrun A.

Blood. 2003 Mar 1;101(5):2001-7.

18.

Induction of fetal hemoglobin synthesis by valproate: modulation of MAP kinase pathways.

Witt O, Mönkemeyer S, Kanbach K, Pekrun A.

Am J Hematol. 2002 Sep;71(1):45-6.

19.
20.

Maintenance of elevated fetal hemoglobin levels by decitabine during dose interval treatment of sickle cell anemia.

DeSimone J, Koshy M, Dorn L, Lavelle D, Bressler L, Molokie R, Talischy N.

Blood. 2002 Jun 1;99(11):3905-8.

Items per page

Supplemental Content

Support Center